Did CEOs and officers buy or sell their own stock?
Open-market trades by the people who know the company best, with their own money.
Last 7 days: the stocks insiders bought and sold most
Stocks Koreans hold most · disclosed Last 7 days · open-market trades only
Bought most
Sold most
Whalegun
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
James G. CoulterOther | Odyssey TherapeuticsODTX | Open-market buy | 05/11 | 05/13 | 1,388,889 sh | $18.00 | $25,000,002 | +60.4% |
Dimension Capital IIDirector | Odyssey TherapeuticsODTX | Open-market buy | 05/08 | 05/12 | 1,111,111 sh | $18.00 | $19,999,998 | +50.0% |
10% Owner | Odyssey TherapeuticsODTX | Open-market buy | 05/11 | 05/11 | 555,555 sh3 trades | $18.00avg. | $9,999,990 | +121.0% |
10% Owner | Odyssey TherapeuticsODTX | Open-market sale | 05/11 | 05/11 | 1,780 sh3 trades | $18.00avg. | $32,040 | −0.2% |
Shelley ChuDirector | Odyssey TherapeuticsODTX | Open-market buy | 05/11 | 05/11 | 11,111 sh | $18.00 | $199,998 | No record |
Nan LiDirector | Odyssey TherapeuticsODTX | Open-market buy | 05/11 | 05/11 | 1,111,111 sh | $18.00 | $19,999,998 | +50.0% |
Jeffrey M. LeidenDirector | Odyssey TherapeuticsODTX | Open-market buy | 05/08 | 05/11 | 5,000 sh | $20.00 | $100,000 | +1.9% |
Jason HaasCFO | Odyssey TherapeuticsODTX | Open-market buy | 05/08 | 05/11 | 1,000 sh | $20.00 | $20,000 | +1.6% |
